Osteocytes: The master cells in bone remodelling

Current Opinion in Pharmacology

Volumn 28, Issue , 2016, Pages 24-30

  Prideaux, Matthew ^a   Findlay, David M ^a   Atkins, Gerald J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BETA CATENIN; BETA INTERFERON; BORTEZOMIB; CALCITONIN RECEPTOR; CATHEPSIN K; COLLAGENASE 3; CONNEXIN 43; DENOSUMAB; DENTIN MATRIX PROTEIN 1; DICKKOPF 1 PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR 23; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 4; MANGANESE SUPEROXIDE DISMUTASE; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; NEUTRALIZING ANTIBODY; NOTCH RECEPTOR; ODANACATIB; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE[1-34]; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; SCLEROSTIN; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BONE DENSITY; BONE MASS; BONE REMODELING; DRUG TARGETING; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BONE; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE AND BONES; BONE REMODELING; HOMEOSTASIS; HUMANS; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; SIGNAL TRANSDUCTION;

EID: 84959354241     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2016.02.003     Document Type: Review

References (60)

1. S.L. Dallas, M. Prideaux, and L.F. Bonewald The osteocyte: an endocrine cell... and more Endocr Rev 34 2013 658 690
2. P.S. Rowe The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled Cell Biochem Funct 30 2012 355 375
3. H.M. Frost The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents Bone Miner 2 1987 73 85
4. G.J. Atkins, and D.M. Findlay Osteocyte regulation of bone mineral: a little give and take Osteoporos Int 23 2012 2067 2079
5. S.Y. Tang, R.P. Herber, S.P. Ho, and T. Alliston Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance J Bone Miner Res 27 2012 1936 1950
6. L.F. Bonewald, and M.L. Johnson Osteocytes, mechanosensing and Wnt signaling Bone 42 2008 606 615
7. M.R. McClung, A. Grauer, S. Boonen, M.A. Bolognese, J.P. Brown, A. Diez-Perez, B.L. Langdahl, J.Y. Reginster, J.R. Zanchetta, S.M. Wasserman, and et al. Romosozumab in postmenopausal women with low bone mineral density N Engl J Med 370 2014 412 420
8. R.R. Recker, C.T. Benson, T. Matsumoto, M.A. Bolognese, D.A. Robins, J. Alam, A.Y. Chiang, L. Hu, J.H. Krege, H. Sowa, and et al. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density J Bone Miner Res 30 2015 216 224
9. C. Thouverey, and J. Caverzasio Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/beta-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro Bonekey Rep 4 2015 757
10. G.J. Atkins, P.S. Rowe, H.P. Lim, K.J. Welldon, R. Ormsby, A.R. Wijenayaka, L. Zelenchuk, A. Evdokiou, and D.M. Findlay Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism J Bone Miner Res 26 2011 1425 1436
11. X. Tu, J. Delgado-Calle, K.W. Condon, M. Maycas, H. Zhang, N. Carlesso, M.M. Taketo, D.B. Burr, L.I. Plotkin, and T. Bellido Osteocytes mediate the anabolic actions of canonical Wnt/beta-catenin signaling in bone Proc Natl Acad Sci U S A 112 2015 E478 E486
12. N. Lara-Castillo, N.A. Kim-Weroha, M.A. Kamel, B. Javaheri, D.L. Ellies, R.E. Krumlauf, G. Thiagarajan, and M.L. Johnson In vivo mechanical loading rapidly activates beta-catenin signaling in osteocytes through a prostaglandin mediated mechanism Bone 76 2015 58 66
13. B. Javaheri, A.R. Stern, N. Lara, M. Dallas, H. Zhao, Y. Liu, L.F. Bonewald, and M.L. Johnson Deletion of a single beta-catenin allele in osteocytes abolishes the bone anabolic response to loading J Bone Miner Res 29 2014 705 715
14. E. Canalis, D.J. Adams, A. Boskey, K. Parker, L. Kranz, and S. Zanotti Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling J Biol Chem 288 2013 25614 25625
15. T. Standal, R.W. Johnson, N.E. McGregor, I.J. Poulton, P.W. Ho, T.J. Martin, and N.A. Sims gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation J Endocrinol 223 2014 181 190
16. L.I. Plotkin, T.L. Speacht, and H.J. Donahue Cx43 and mechanotransduction in bone Curr Osteoporos Rep 13 2015 67 72
17. N. Bivi, R. Pacheco-Costa, L.R. Brun, T.R. Murphy, N.R. Farlow, A.G. Robling, T. Bellido, and L.I. Plotkin Absence of Cx43 selectively from osteocytes enhances responsiveness to mechanical force in mice J Orthop Res 31 2013 1075 1081
18. H. Xu, S. Gu, M.A. Riquelme, S. Burra, D. Callaway, H. Cheng, T. Guda, J. Schmitz, R.J. Fajardo, S.L. Werner, and et al. Connexin 43 channels are essential for normal bone structure and osteocyte viability J Bone Miner Res 30 2015 436 448
19. K. Kobayashi, H. Nojiri, Y. Saita, D. Morikawa, Y. Ozawa, K. Watanabe, M. Koike, Y. Asou, T. Shirasawa, K. Yokote, and et al. Mitochondrial superoxide in osteocytes perturbs canalicular networks in the setting of age-related osteoporosis Sci Rep 5 2015 9148
20. J. Klein-Nulend, R.F. van Oers, A.D. Bakker, and R.G. Bacabac Bone cell mechanosensitivity, estrogen deficiency, and osteoporosis J Biomech 48 2015 855 865
21. G. Zaman, H.L. Jessop, M. Muzylak, R.L. De Souza, A.A. Pitsillides, J.S. Price, and L.L. Lanyon Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen J Bone Miner Res 21 2006 1297 1306
22. J.I. Aguirre, L.I. Plotkin, A.R. Gortazar, M.M. Millan, C.A. O'Brien, S.C. Manolagas, and T. Bellido A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction J Biol Chem 282 2007 25501 25508
23. S.H. Windahl, A.E. Borjesson, H.H. Farman, C. Engdahl, S. Moverare-Skrtic, K. Sjogren, M.K. Lagerquist, J.M. Kindblom, A. Koskela, J. Tuukkanen, and et al. Estrogen receptor-alpha in osteocytes is important for trabecular bone formation in male mice Proc Natl Acad Sci U S A 110 2013 2294 2299
24. S.W. Verbruggen, M.J. Mc Garrigle, M.G. Haugh, M.C. Voisin, and L.M. McNamara Altered mechanical environment of bone cells in an animal model of short- and long-term osteoporosis Biophys J 108 2015 1587 1598
25. C. Ciani, D. Sharma, S.B. Doty, and S.P. Fritton Ovariectomy enhances mechanical load-induced solute transport around osteocytes in rat cancellous bone Bone 59 2014 229 234
26. K.B. Emerton, B. Hu, A.A. Woo, A. Sinofsky, C. Hernandez, R.J. Majeska, K.J. Jepsen, and M.B. Schaffler Osteocyte apoptosis and control of bone resorption following ovariectomy in mice Bone 46 2010 577 583
27. S. Fukumoto FGF23-FGF receptor/klotho pathway as a new drug target for disorders of bone and mineral metabolism Calcif Tissue Int 2015 10.1007/s00223-015-0029-y
28. K.A. Staines, V.E. MacRae, and C. Farquharson The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling J Endocrinol 214 2012 241 255
29. N. Ito, A.R. Wijenayaka, M. Prideaux, M. Kogawa, R.T. Ormsby, A. Evdokiou, L.F. Bonewald, D.M. Findlay, and G.J. Atkins Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli Mol Cell Endocrinol 399 2015 208 218
30. X. Wang, J. Wang, B. Yuan, Y. Lu, J.Q. Feng, and C. Qin Overexpression of Dmp1 fails to rescue the bone and dentin defects in Fam20C knockout mice Connect Tissue Res 55 2014 299 303
31. T. Nakashima, M. Hayashi, T. Fukunaga, K. Kurata, M. Oh-Hora, J.Q. Feng, L.F. Bonewald, T. Kodama, A. Wutz, E.F. Wagner, and et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression Nat Med 17 2011 1231 1234
32. J. Xiong, M. Onal, R.L. Jilka, R.S. Weinstein, S.C. Manolagas, and C.A. O'Brien Matrix-embedded cells control osteoclast formation Nat Med 17 2011 1235 1241
33. J. Xiong, M. Piemontese, M. Onal, J. Campbell, J.J. Goellner, V. Dusevich, L. Bonewald, S.C. Manolagas, and C.A. O'Brien Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone PLoS One 10 2015 e0138189
34. A.N. Ben-awadh, J. Delgado-Calle, X. Tu, K. Kuhlenschmidt, M.R. Allen, L.I. Plotkin, and T. Bellido Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes Endocrinology 155 2014 2797 2809
35. M. Honma, Y. Ikebuchi, Y. Kariya, M. Hayashi, N. Hayashi, S. Aoki, and H. Suzuki RANKL subcellular trafficking and regulatory mechanisms in osteocytes J Bone Miner Res 28 2013 1936 1949
36. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Luthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, and et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
37. A.R. Wijenayaka, M. Kogawa, H.P. Lim, L.F. Bonewald, D.M. Findlay, and G.J. Atkins Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway PLoS One 6 2011 e25900
38. J.M. Spatz, M.N. Wein, J.H. Gooi, Y. Qu, J.L. Garr, S. Liu, K.J. Barry, Y. Uda, F. Lai, C. Dedic, and et al. The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro J Biol Chem 290 2015 16744 16758
39. S. Chen, J. Feng, Q. Bao, A. Li, B. Zhang, Y. Shen, Y. Zhao, Q. Guo, J. Jing, S. Lin, and et al. Adverse effects of osteocytic constitutive activation of β-catenin on bone strength and bone growth J Bone Miner Res 30 2015 1184 1194
40. C. Hayashida, J. Ito, M. Nakayachi, M. Okayasu, Y. Ohyama, Y. Hakeda, and T. Sato Osteocytes produce interferon-beta as a negative regulator of osteoclastogenesis J Biol Chem 289 2014 11545 11555
41. L.I. Plotkin, A.R. Gortazar, H.M. Davis, K.W. Condon, H. Gabilondo, M. Maycas, M.R. Allen, and T. Bellido Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor kappaB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading J Biol Chem 290 2015 18934 18942
42. L. Cardoso, B.C. Herman, O. Verborgt, D. Laudier, R.J. Majeska, and M.B. Schaffler Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue J Bone Miner Res 24 2009 597 605
43. O.D. Kennedy, D.M. Laudier, R.J. Majeska, H.B. Sun, and M.B. Schaffler Osteocyte apoptosis is required for production of osteoclastogenic signals following bone fatigue in vivo Bone 64 2014 132 137
44. L.F. Belanger, C. Belanger, and T. Semba Technical approaches leading to the concept of osteocytic osteolysis Clin Orthop Relat Res 54 1967 187 196
45. H. Qing, L. Ardeshirpour, P.D. Pajevic, V. Dusevich, K. Jahn, S. Kato, J. Wysolmerski, and L.F. Bonewald Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation J Bone Miner Res 27 2012 1018 1029
46. S.A. Lloyd, A.E. Loiselle, Y. Zhang, and H.J. Donahue Evidence for the role of connexin 43-mediated intercellular communication in the process of intracortical bone resorption via osteocytic osteolysis BMC Musculoskelet Disord 15 2014 122
47. M.O. Hajjawi, V.E. MacRae, C. Huesa, A. Boyde, J.L. Millan, T.R. Arnett, and I.R. Orriss Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(-/-) mice Bone 69 2014 139 147
48. B. Javaheri, A. Carriero, K.A. Staines, Y.M. Chang, D.A. Houston, K.J. Oldknow, J.L. Millan, B.N. Kazeruni, P. Salmon, S. Shefelbine, and et al. Phospho1 deficiency transiently modifies bone architecture yet produces consistent modification in osteocyte differentiation and vascular porosity with ageing Bone 81 2015 277 291
49. M.V. Clarke, P.K. Russell, D.M. Findlay, S. Sastra, P.H. Anderson, J.P. Skinner, G.J. Atkins, J.D. Zajac, and R.A. Davey A role for the calcitonin receptor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis Endocrinology 156 2015 3203 3214
50. M. Kogawa, A.R. Wijenayaka, R.T. Ormsby, G.P. Thomas, P.H. Anderson, L.F. Bonewald, D.M. Findlay, and G.J. Atkins Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2 J Bone Miner Res 28 2013 2436 2448
51. J.J. Wysolmerski Osteocytes remove and replace perilacunar mineral during reproductive cycles Bone 54 2013 230 236
52. V. David, A. Martin, A.M. Hedge, M.K. Drezner, and P.S. Rowe ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate Am J Physiol Renal Physiol 300 2011 F783 F791
53. O. Leupin, E. Piters, C. Halleux, S. Hu, I. Kramer, F. Morvan, T. Bouwmeester, M. Schirle, M. Bueno-Lozano, F.J. Fuentes, and et al. Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function J Biol Chem 286 2011 19489 19500
54. M.K. Chang, I. Kramer, T. Huber, B. Kinzel, S. Guth-Gundel, O. Leupin, and M. Kneissel Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels Proc Natl Acad Sci U S A 111 2014 E5187 E5195
55. B.C. Silva, A.G. Costa, N.E. Cusano, S. Kousteni, and J.P. Bilezikian Catabolic and anabolic actions of parathyroid hormone on the skeleton J Endocrinol Invest 34 2011 801 810
56. N. Ito, D.M. Findlay, and G.J. Atkins Osteocyte communication with the kidney via the production of FGF23: remote control of phosphate homeostasis Clin Rev Bone & Miner Metab 12 2014 44 58
57. S.C. Pageau Denosumab MAbs 1 2009 210 215
58. J.Y. Gauthier, N. Chauret, W. Cromlish, S. Desmarais, L.T. Duong, J.P. Falgueyret, D.B. Kimmel, S. Lamontagne, S. Leger, T. LeRiche, and et al. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K Bioorg Med Chem Lett 18 2008 923 928
59. D. Toscani, C. Palumbo, B. Dalla Palma, M. Ferretti, M. Bolzoni, V. Marchica, P. Sena, E. Martella, C. Mancini, V. Ferri, and et al. The proteasome inhibitor, bortezomib, maintains osteocyte viability in multiple myeloma patients by reducing both apoptosis and autophagy: a new function for proteasome inhibitors J Bone Miner Res 2015 10.1002/jbmr.2741
60. K.A. Staines, M. Prideaux, D.J. Buttle, A.A. Pitsillides, and C. Farquharson E11/podoplanin protein stabilization through inhibition of the proteasome promotes osteocyte differentiation in murine in vitro models J Cell Physiol 2015 10.1002/jcp.25282